Aminologics Co.,Ltd. (KOSDAQ:074430)

Aminologics Revenue

Aminologics had revenue of 8.25B KRW in the quarter ending June 30, 2026, with 73.10% growth. This brings the company's total for the last twelve months to 26.16B, up 64.47% year-over-year. In the year 2025, Aminologics had annual revenue of 22.02B with 31.15% growth. That makes Aminologics the 34,005th largest company in the world by revenue and 2,172nd in South Korea.

• Revenue (ttm): 26.16B
• Revenue Growth: +64.47%
• P/S Ratio: 3.40
• Revenue / Employee: 638.00M
• Employees: 41
• Market Cap: 88.85B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Amino Acid 17.69B 80.3%
• Raw Drug Product 4.33B 19.7%

By Geography

Chart

• Overseas 16.56B 75.2%
• South Korea 5.46B 24.8%

Fiscal year ended Dec 31, 2025 See the full Aminologics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	22.02B	5.23B	31.15%
Dec 31, 2024	16.79B	-4.10B	-19.61%
Dec 31, 2023	20.89B	-6.45B	-23.60%
Dec 31, 2022	27.34B	4.49B	19.64%
Dec 31, 2021	22.85B	5.20B	29.45%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error